Abstract
Traditional multi-armed bandit algorithms focus on maximizing cumulative rewards. However, in critical domains like healthcare, the objective is often "leveling"—maintaining an outcome near a specific target while adhering to strict safety constraints. This paper introduces SALE-LTS (Safe Leveling via Linear Thompson Sampling), an algorithm designed to minimize regret relative to a target level while respecting two-sided safety bounds. Evaluated on a high-fidelity Type 1 Diabetes simulator, SALE-LTS demonstrates near-perfect safety and superior performance compared to standard clinical calculators and human experts.
Introduction
In many real-world applications, the "more is better" philosophy of standard bandits is inappropriate. For instance, in blood pressure management or insulin dosing, the goal is to maintain a physiological variable within a "Goldilocks zone." Deviations in either direction—too high or too low—can be dangerous.
Existing "safe" bandit literature often focuses on one-sided constraints (e.g., lower bounds) and reward maximization. This paper addresses two critical gaps:
- The Leveling Objective: Shifting the focus from maximization to keeping outcomes close to a target level $K$.
- Two-Sided Safety: Ensuring outcomes remain between a lower bound ($C_1$) and an upper bound ($C_2$).
A primary motivating example is Type 1 Diabetes management, where insulin doses must be precisely calibrated to avoid both hyperglycemia and life-threatening hypoglycemia.
Methodology
The authors propose SALE-LTS, which integrates safety constraints into the Linear Thompson Sampling (LTS) framework. The algorithm operates by maintaining a confidence region for the environment's parameters and restricting its actions to a "proxy safe set."
Key Components
- Proxy Safe Set Construction: At each round $t$, the algorithm computes a confidence region $\mathcal{C}_t(\delta')$ for the unknown parameter $\theta_*$. It then identifies a subset of actions $\hat{\mathcal{X}}_t^s$ that are guaranteed to yield outcomes within $[C_1, C_2]$ for all $\theta \in \mathcal{C}_t(\delta')$.
- Leveling Acquisition Strategy: Unlike standard LTS, which selects actions to maximize expected reward, SALE-LTS selects the action from the safe set (or a small initial seed set $\mathcal{X}_1^{iss}$) that minimizes the distance between the predicted outcome and the target $K$.
- Optimism in Leveling: In this context, "optimism" implies assuming there exists a parameter within the uncertainty range that allows the target $K$ to be hit exactly.
The authors prove that SALE-LTS achieves sublinear regret, matching the efficiency of standard unsafe LTS while maintaining strict safety guarantees.
Experimental Evaluation
The algorithm was tested using the UVa/PADOVA T1DM Simulator, an FDA-recognized high-fidelity model for postprandial blood glucose (PPBG) levels.
Setup
- Subjects: 30 virtual patients (10 children, 10 adolescents, 10 adults).
- Baselines: Standard formula-based "tuned calculators" and recommendations from human clinicians.
- Metrics: Safe frequency (percentage of rounds within bounds) and Risk Index (distance from target).
Results and Discussion
SALE-LTS demonstrated exceptional performance across all categories:
- Safety: The algorithm achieved a Safe Frequency of 0.999, effectively eliminating safety violations. In contrast, an unsafe variant (LE-LTS) had a safety frequency of only 0.756 in initial rounds.
- Accuracy: SALE-LTS maintained blood glucose levels significantly closer to the target (112.5 mg/dl) than standard calculators.
- Clinical Comparison: In experiments against human clinicians, SALE-LTS achieved a lower Risk Index (3.123 vs. 7.878), primarily due to its superior ability to avoid hyperglycemia without inducing hypoglycemia.
Inter-Contextual Learning
A significant finding was the algorithm's ability to perform inter-contextual learning. By modeling the patient's general response, the algorithm could generalize knowledge across different contexts (e.g., different meal sizes), leading to faster personalization than traditional trial-and-error methods.
Conclusion and Future Work
SALE-LTS provides a robust framework for safe leveling in linear environments. While highly effective in simulation, future work must address the linearity assumption, as real biological systems are often non-linear and time-varying. Additionally, the requirement for an initial "seed set" of safe actions remains a practical hurdle for entirely unknown environments. Moving toward in vivo clinical settings will require further robustness to real-world noise and unmodeled patient behaviors.
Summary updated